N. Hirabayashi

The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue.

N. Tanaka, Y. Matsuzaki, T. Ikegami, 1998, Cancer letters.

Analysis of the damaged components of permed hair using biochemical technique

N. Hirabayashi, R. Kon, A. Nakamura, 1998 .

Effect of sodium tauroursodeoxycholate (UR-906) on liver dysfunction in bile duct-ligated rats.

H. Kasai, Y. Takeuchi, K. Ishizaki, 1997, European journal of pharmacology.

Effect of sodium tauroursodeoxycholate on phalloidin-induced cholestasis in rats.

K. Ishizaki, N. Hirabayashi, K. Uchiyama, 2001, European Journal of Pharmacology.

The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.

H. Kasai, Y. Takeuchi, K. Ishizaki, 1998, European journal of pharmacology.

Improvement of estradiol-17 beta-D-glucuronide-induced cholestasis by sodium tauroursodeoxycholate therapy in rats.

H. Kasai, K. Ishizaki, N. Hirabayashi, 1997, Scandinavian journal of gastroenterology.

The biochemical studies on phalloidin-induced cholestasis in rats.

H. Kasai, Y. Takeuchi, K. Ishizaki, 1997, Toxicology letters.

Pharmacokinetics of a new histamine H2-receptor antagonist, Z-300, in rat and dog.

T. Ito, M. Suzuki, T. Sugimoto, 1999, Xenobiotica; the fate of foreign compounds in biological systems.